Credit Suisse Ag Ionis Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Credit Suisse Ag holds 182,509 shares of IONS stock, worth $6.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

182,509

Previous 189,722 3.8%

Holding current value

$6.88 Million

Previous $9.6 Million 17.58%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$42.03 - $53.55 $303,162 - $386,256	-7,213 Reduced 3.8%	182,509 $7.91 Million
Q4 2023 Feb 08, 2024	SELL	$43.39 - $51.63 $1.76 Million - $2.1 Million	-40,621 Reduced 17.64%	189,722 $9.6 Million
Q3 2023 Nov 13, 2023	SELL	$38.5 - $47.13 $563,601 - $689,936	-14,639 Reduced 5.98%	230,343 $10.4 Million
Q2 2023 Aug 11, 2023	BUY	$34.73 - $43.33 $101,099 - $126,133	2,911 Added 1.2%	244,982 $10.1 Million
Q1 2023 May 10, 2023	BUY	$33.58 - $41.2 $1.94 Million - $2.38 Million	57,769 Added 31.34%	242,071 $8.65 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $1.1 Million - $1.38 Million	29,604 Added 19.14%	184,302 $6.96 Million
Q3 2022 Nov 10, 2022	BUY	$36.54 - $48.66 $181,859 - $242,180	4,977 Added 3.32%	154,698 $6.84 Million
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $979,997 - $1.33 Million	-30,905 Reduced 17.11%	149,721 $5.54 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $115,306 - $142,937	3,859 Added 2.18%	180,626 $6.69 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $150,970 - $206,914	-5,895 Reduced 3.23%	176,767 $5.38 Million
Q3 2021 Nov 12, 2021	BUY	$33.54 - $40.55 $787,418 - $951,992	23,477 Added 14.75%	182,662 $6.13 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $904,637 - $1.24 Million	26,191 Added 19.69%	159,185 $6.35 Million
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $505,613 - $758,599	-11,894 Reduced 8.21%	132,994 $5.98 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $1.05 Million - $1.4 Million	-23,155 Reduced 13.78%	144,888 $8.19 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $381,687 - $506,369	-8,044 Reduced 4.57%	168,043 $7.97 Million
Q2 2020 Aug 12, 2020	BUY	$46.85 - $61.05 $1.94 Million - $2.53 Million	41,456 Added 30.79%	176,087 $10.4 Million
Q1 2020 May 13, 2020	BUY	$41.6 - $63.4 $341,036 - $519,753	8,198 Added 6.48%	134,631 $6.37 Million
Q4 2019 Feb 12, 2020	BUY	$53.85 - $65.27 $1.05 Million - $1.28 Million	19,558 Added 18.3%	126,433 $7.64 Million
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $9.74 Million - $11.9 Million	-164,922 Reduced 60.68%	106,875 $6.4 Million
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $4.81 Million - $6.68 Million	-77,522 Reduced 22.19%	271,797 $17.5 Million
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $8.34 Million - $12.8 Million	-157,559 Reduced 31.08%	349,319 $28.4 Million
Q4 2018 Feb 13, 2019	SELL	$43.37 - $59.54 $2.15 Million - $2.95 Million	-49,618 Reduced 8.92%	506,878 $27.4 Million
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $404,358 - $506,391	9,430 Added 1.72%	556,496 $28.7 Million
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $8.42 Million - $10.5 Million	-207,745 Reduced 27.52%	547,066 $22.8 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $13.3 Million - $16.6 Million	301,872 Added 66.65%	754,811 $33.3 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $6.96 Million - $8.9 Million	138,275 Added 43.94%	452,939 $22.8 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $1.68 Million - $2.19 Million	36,766 Added 13.23%	314,664 $16 Million
Q2 2017 Aug 14, 2017	BUY	N/A	277,898	277,898 $14.1 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account